$174.40
0.35% today
Nasdaq, Nov 04, 09:12 pm CET
ISIN
US09062X1037
Symbol
BIIB
Sector
Industry

Biogen Target price 2024 - Analyst rating & recommendation

Biogen Classifications & Recommendation:

Buy
65%
Hold
35%

Biogen Price Target

Target Price $254.56
Price $173.79
Potential 46.47%
Number of Estimates 27
27 Analysts have issued a price target Biogen 2025 . The average Biogen target price is $254.56. This is 46.47% higher than the current stock price. The highest price target is $342.00 96.79% , the lowest is $180.00 3.57% .
A rating was issued by 37 analysts: 24 Analysts recommend Biogen to buy, 13 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Biogen stock has an average upside potential 2025 of 46.47% . Most analysts recommend the Biogen stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028


Dec '23 2024
Estimates
Revenue Billion $ 9.42 9.63
0.17% 2.29%
EBITDA Margin 22.58% 35.21%
23.74% 55.95%
Net Margin 12.33% 18.41%
61.74% 49.30%

29 Analysts have issued a sales forecast Biogen 2024 . The average Biogen sales estimate is $9.6b . This is 4.38% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $9.7b 5.60% , the lowest is $9.5b 2.49% .

This results in the following potential growth metrics:

Revenue Estimates

2023 $9.4b 0.17%
2024 $9.6b 2.29%
2025 $9.5b 0.92%
2026 $9.7b 1.73%
2027 $10.0b 2.83%
2028 $10.1b 1.26%

9 Analysts have issued an Biogen EBITDA forecast 2024. The average Biogen EBITDA estimate is $3.4b . This is 23.42% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.9b 43.63% , the lowest is $3.0b 7.46% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $2.1b 23.87%
2024 $3.4b 59.53%
2025 $3.6b 5.92%
2026 $3.7b 2.31%
2027 $4.3b 16.39%
2028 $4.9b 15.37%

EBITDA Margin

2023 22.58% 23.74%
2024 35.21% 55.95%
2025 37.64% 6.90%
2026 37.86% 0.58%
2027 42.85% 13.18%
2028 48.82% 13.93%

12 Biogen Analysts have issued a net profit forecast 2024. The average Biogen net profit estimate is $1.8b . This is 9.96% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.1b 30.08% , the lowest is $1.6b 2.53% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $1.2b 61.81%
2024 $1.8b 52.72%
2025 $2.1b 16.20%
2026 $2.5b 20.70%
2027 $2.8b 14.46%
2028 $3.2b 10.74%

Net Margin

2023 12.33% 61.74%
2024 18.41% 49.30%
2025 21.59% 17.27%
2026 25.62% 18.67%
2027 28.52% 11.32%
2028 31.18% 9.33%

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028


Dec '23 2024
Estimates
Earnings Per Share $ 7.97 12.17
61.81% 52.70%
P/E 14.28
EV/Sales 3.14

12 Analysts have issued a Biogen forecast for earnings per share. The average Biogen <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $12.17 . This is 9.94% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $14.40 30.08% , the lowest is $10.79 2.53% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $7.97 61.81%
2024 $12.17 52.70%
2025 $14.14 16.19%
2026 $17.07 20.72%
2027 $19.54 14.47%
2028 $21.64 10.75%

P/E ratio

Current 15.70 22.94%
2024 14.28 9.04%
2025 12.29 13.94%
2026 10.18 17.17%
2027 8.89 12.67%
2028 8.03 9.67%

Based on analysts' sales estimates for 2024, the Biogen stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 3.14 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 2.63 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.28 9.89%
2024 3.14 4.17%
2025 3.17 0.93%
2026 3.12 1.71%
2027 3.03 2.75%
2028 2.99 1.25%

P/S ratio

Current 2.74 23.49%
2024 2.63 4.19%
2025 2.65 0.93%
2026 2.61 1.70%
2027 2.54 2.75%
2028 2.50 1.25%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today